The Impact of Translational Research in Hepatology

Johann von Felden; Amanda J. Craig; Augusto Villanueva

doi:10.1002/cld.805

The Impact of Translational Research in Hepatology

Johann von Felden, Amanda J. Craig, Augusto Villanueva

Research output: Contribution to journal › Review article › peer-review

2 Scopus citations

Original language	English
Pages (from-to)	29-33
Number of pages	5
Journal	Clinical Liver Disease
Volume	13
Issue number	1
DOIs	https://doi.org/10.1002/cld.805
State	Published - Jan 2019

Access to Document

10.1002/cld.805

Cite this

@article{eb700ccdeeec4043bf8caad421091b3a,

title = "The Impact of Translational Research in Hepatology",

author = "{von Felden}, Johann and Craig, {Amanda J.} and Augusto Villanueva",

note = "Funding Information: Abbreviations: ALK, anaplastic lymphoma kinase gene; BRAF, b-rapidly accelerated fibrosarcoma gene; BRCA, breast cancer gene; DAA, direct-acting antiviral; EGFR, epidermal growth factor receptor; ERBB2, erythroblastic oncogene 2 (synonym: HER2); FDA, Food and Drug Administration; FISH, fluorescent in situ hybridization; GIST, gastrointestinal stroma tumor; HCC, hepatocellular carcinoma; HCV, hepatitis C virus; HER2, human epidermal growth factor 2; HR, hormone receptor; IFN, interferon; IHC, immunohistochemistry; KRAS, k-rat sarcoma gene; NSCLC, non-small-cell lung cancer; NGS, next generation sequencing; PCR, polymerase chain reaction; PD-L1, programmed cell death ligand-1; SNP, single-nucleotide polymorphism; SVR, sustained virological response. From the *Division of Liver Diseases, Department of Medicine, Liver Cancer Program, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY; †Department of Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany; and ‡Division of Hematology and Medical Oncology, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY. J.v.F. was supported by the German Research Foundation (FE 1746/1-1). A.J.C. was supported by the National Cancer Institute Ruth L. Kirschstein NRSA Institutional Research Training Grant (CA078207). A.V. was supported by the US Department of Defense (grant CA150272P3) and the Tisch Cancer Institute (Cancer Center grant P30 CA196521). Potential conflict of interest: Nothing to report. Received October 1, 2018; accepted January 2, 2019.",

year = "2019",

month = jan,

doi = "10.1002/cld.805",

language = "English",

volume = "13",

pages = "29--33",

journal = "Clinical Liver Disease",

issn = "2046-2484",

publisher = "John Wiley and Sons Ltd",

number = "1",

}

TY - JOUR

T1 - The Impact of Translational Research in Hepatology

AU - von Felden, Johann

AU - Craig, Amanda J.

AU - Villanueva, Augusto

N1 - Funding Information: Abbreviations: ALK, anaplastic lymphoma kinase gene; BRAF, b-rapidly accelerated fibrosarcoma gene; BRCA, breast cancer gene; DAA, direct-acting antiviral; EGFR, epidermal growth factor receptor; ERBB2, erythroblastic oncogene 2 (synonym: HER2); FDA, Food and Drug Administration; FISH, fluorescent in situ hybridization; GIST, gastrointestinal stroma tumor; HCC, hepatocellular carcinoma; HCV, hepatitis C virus; HER2, human epidermal growth factor 2; HR, hormone receptor; IFN, interferon; IHC, immunohistochemistry; KRAS, k-rat sarcoma gene; NSCLC, non-small-cell lung cancer; NGS, next generation sequencing; PCR, polymerase chain reaction; PD-L1, programmed cell death ligand-1; SNP, single-nucleotide polymorphism; SVR, sustained virological response. From the *Division of Liver Diseases, Department of Medicine, Liver Cancer Program, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY; †Department of Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany; and ‡Division of Hematology and Medical Oncology, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY. J.v.F. was supported by the German Research Foundation (FE 1746/1-1). A.J.C. was supported by the National Cancer Institute Ruth L. Kirschstein NRSA Institutional Research Training Grant (CA078207). A.V. was supported by the US Department of Defense (grant CA150272P3) and the Tisch Cancer Institute (Cancer Center grant P30 CA196521). Potential conflict of interest: Nothing to report. Received October 1, 2018; accepted January 2, 2019.

PY - 2019/1

Y1 - 2019/1

UR - http://www.scopus.com/inward/record.url?scp=85061893614&partnerID=8YFLogxK

U2 - 10.1002/cld.805

DO - 10.1002/cld.805

M3 - Review article

AN - SCOPUS:85061893614

SN - 2046-2484

VL - 13

SP - 29

EP - 33

JO - Clinical Liver Disease

JF - Clinical Liver Disease

IS - 1

ER -